Skip to main content
. 2018 Mar 6;2018:5474903. doi: 10.1155/2018/5474903

Figure 2.

Figure 2

One month following presentation, following intravitreal bevacizumab #1. (a) TOP: optical coherence tomography angiography (OCT-A) retina slab demonstrates reduced signal due to artifact and decreased flow signal through the retinal arterial macroaneurysm (RAM). BOTTOM: spectral domain optical coherence tomography (SD-OCT) reveals reduced submacular fluid. (b) TOP: OCT-A superficial slab shows reduced signal due to artifact and decreased flow signal through the RAM. BOTTOM: SD-OCT reveals decreased submacular fluid.